×

Subcribe to Mid-day Gold with just Rs. 899 /Year

Home > Entertainment News > Hollywood News > Article > When Keanu Reeves donated 70 per cent of The Matrix salary to cancer research

When Keanu Reeves donated 70 per cent of 'The Matrix' salary to cancer research

Updated on: 05 January,2022 09:33 AM IST  |  Washington
ANI |

As per New York Post, Reeves was paid USD 10 million upfront for the 1999 sci-fi drama, before earning a further USD 35 million when the movie became a hit. Almost USD 31.6 million went into leukemia research

When Keanu Reeves donated 70 per cent of 'The Matrix' salary to cancer research

Keanu Reeves. Pic/AFP


Keanu Reeves is surely one of the most charitable stars in Hollywood. Reportedly, he had donated 70 per cent of his salary from the original 'The Matrix' film to cancer research.


As per New York Post, Reeves was paid USD 10 million upfront for the 1999 sci-fi drama, before earning a further USD 35 million when the movie became a hit. Almost USD 31.6 million went into leukemia research.



The particular donation was made at a time when Reeves' younger sister, Kim, had been battling cancer.


Kim was diagnosed with blood cancer in 1991. Reeves even created a charity foundation to help those battling cancer. He had chosen to not attach his name to the foundation as he wanted to run it privately.

Also, in 2020, Reeves reportedly auctioned off a 15-minute virtual Zoom date to raise money for children dealing with the deadly disease. Isn't he empathetic?

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK